Literature DB >> 31055642

Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.

George K Papadimas1, Charalampos Kokkinis2, Sophia Xirou3, Margarita Chrysanthou3, Evangelia Kararizou3, Constantinos Papadopoulos3.   

Abstract

Polymyositis with mitochondrial pathology (PM-Mito) is a rare form of idiopathic inflammatory myopathy with no definite diagnostic criteria and similarities to both PM and sporadic inclusion body myositis (s-IBM). The aim of this study is to address the dilemma of whether PM-Mito is a subtype of inflammatory myopathy or represents a disease falling into the spectrum of s-IBM. Herein, we report four female patients diagnosed with PM-Mito, highlighting their rather atypical clinical and histopathological characteristics that seem to indicate a diagnosis away from s-IBM. Muscle weakness was rather proximal and symmetrical and lacked the selective pattern observed in s-IBM. Patients had large-scale deletions in mtDNA, reflecting the mitochondrial component in the pathology of the disease. Conclusively, our study adds to the limited data in the literature on whether PM-Mito is a distinct form of myositis or represents a prodromal stage of s-IBM. Although the latter seems to be supported by a substantial body of evidence, there are, however, important differences, such as the different patterns of muscle weakness, and the good response to treatment observed in some patients. Larger-scale studies are certainly needed to clarify pathogenesis and clinical characteristics of PM-Mito patients, especially in therapeutic and prognostic terms.

Entities:  

Keywords:  Inclusion body myositis; Mitochondria; Polymyositis; mtDNA

Mesh:

Substances:

Year:  2019        PMID: 31055642     DOI: 10.1007/s00296-019-04314-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

Review 1.  Immunological profile in primary Sjögren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease.

Authors:  A L Fauchais; C Martel; G Gondran; M Lambert; D Launay; M O Jauberteau; E Hachulla; E Vidal; P Y Hatron
Journal:  Autoimmun Rev       Date:  2010-05-10       Impact factor: 9.754

Review 2.  Mitochondrial abnormalities in inclusion-body myositis.

Authors:  A Oldfors; A R Moslemi; L Jonasson; M Ohlsson; G Kollberg; C Lindberg
Journal:  Neurology       Date:  2006-01-24       Impact factor: 9.910

Review 3.  Mitochondrial DNA mutations in disease and aging.

Authors:  Douglas C Wallace
Journal:  Environ Mol Mutagen       Date:  2010-06       Impact factor: 3.216

4.  Cores in hypothyroid myopathy: a clinical, histological and immunofluorescence study.

Authors:  G Modi
Journal:  J Neurol Sci       Date:  2000-04-01       Impact factor: 3.181

5.  Hypothyroid myopathy with unusually high serum creatine kinase values.

Authors:  J Finsterer; C Stöllberger; C Grossegger; A Kroiss
Journal:  Horm Res       Date:  1999

6.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

7.  Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy.

Authors:  J M Florence; S Pandya; W M King; J D Robison; J Baty; J P Miller; J Schierbecker; L C Signore
Journal:  Phys Ther       Date:  1992-02

8.  Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients.

Authors:  Sophie Delalande; Jérôme de Seze; Anne-Laure Fauchais; Eric Hachulla; Tanya Stojkovic; Didier Ferriby; Sylvain Dubucquoi; Jean-Pierre Pruvo; Patrick Vermersch; Pierre-Yves Hatron
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

9.  Inflammatory myopathies with mitochondrial pathology and protein aggregates.

Authors:  Peyker Temiz; Conrad C Weihl; Alan Pestronk
Journal:  J Neurol Sci       Date:  2008-12-20       Impact factor: 3.181

10.  Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients.

Authors:  Terry H Oh; Kathlyn A Brumfield; Tanya L Hoskin; Kathryn A Stolp; Joseph A Murray; Jeffrey R Bassford
Journal:  Mayo Clin Proc       Date:  2007-04       Impact factor: 7.616

View more
  3 in total

Review 1.  Inclusion body myositis and associated diseases: an argument for shared immune pathologies.

Authors:  Christopher Nelke; Felix Kleefeld; Corinna Preusse; Tobias Ruck; Werner Stenzel
Journal:  Acta Neuropathol Commun       Date:  2022-06-03       Impact factor: 7.578

2.  A Mutation in the Mitochondrial Aspartate/Glutamate Carrier Leads to a More Oxidizing Intramitochondrial Environment and an Inflammatory Myopathy in Dutch Shepherd Dogs.

Authors:  G Diane Shelton; Katie M Minor; Kefeng Li; Jane C Naviaux; Jon Monk; Lin Wang; Elizabeth Guzik; Ling T Guo; Vito Porcelli; Ruggiero Gorgoglione; Francesco M Lasorsa; Peter J Leegwater; Antonio M Persico; James R Mickelson; Luigi Palmieri; Robert K Naviaux
Journal:  J Neuromuscul Dis       Date:  2019

Review 3.  Inclusion body myositis: Update on the diagnostic and therapeutic landscape.

Authors:  Elie Naddaf
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.